VICCGI0906 Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) with Erlotinib in Patients with Advanced Biliary Tract Cancer.

Trial Profile

VICCGI0906 Phase Ib Trial of Gemcitabine and Oxaliplatin (GEMOX) with Erlotinib in Patients with Advanced Biliary Tract Cancer.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Jul 2017

At a glance

  • Drugs Erlotinib (Primary) ; Gemcitabine; Oxaliplatin
  • Indications Biliary cancer; Duodenal cancer; Pancreatic cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 29 Jun 2017 Status changed from active, no longer recruiting to completed.
    • 10 Jun 2017 Biomarkers information updated
    • 16 Nov 2016 Results analysing safety published in the Investigational New Drugs.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top